Literature DB >> 19254666

Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.

Ray E Hershberger1, Joann Lindenfeld, Luisa Mestroni, Christine E Seidman, Matthew R G Taylor, Jeffrey A Towbin.   

Abstract

Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.

Entities:  

Mesh:

Year:  2009        PMID: 19254666     DOI: 10.1016/j.cardfail.2009.01.006

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  158 in total

Review 1.  The Role of Genetics in Peripartum Cardiomyopathy.

Authors:  Yi Zhen Joan Lee; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2017-08-03       Impact factor: 4.132

2.  Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

Authors:  Ana Morales; Thomas Painter; Ran Li; Jill D Siegfried; Duanxiang Li; Nadine Norton; Ray E Hershberger
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

Review 3.  Self and non-self discrimination is needed for the existence rather than deletion of autoimmunity: the role of regulatory T cells in protective autoimmunity.

Authors:  M Schwartz; J Kipnis
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

4.  Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts.

Authors:  Els Geelen; Klasien Horstman; Carlo L M Marcelis; Pieter A Doevendans; Ine Van Hoyweghen
Journal:  Eur J Hum Genet       Date:  2012-03-28       Impact factor: 4.246

Review 5.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

6.  Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.

Authors:  Neal K Lakdawala; Lisa Dellefave; Charles S Redwood; Elizabeth Sparks; Allison L Cirino; Steve Depalma; Steven D Colan; Birgit Funke; Rebekah S Zimmerman; Paul Robinson; Hugh Watkins; Christine E Seidman; J G Seidman; Elizabeth M McNally; Carolyn Y Ho
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

Review 7.  A new era in clinical genetic testing for hypertrophic cardiomyopathy.

Authors:  Matthew Wheeler; Aleksandra Pavlovic; Emil DeGoma; Heidi Salisbury; Colleen Brown; Euan A Ashley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-30       Impact factor: 4.132

8.  ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.

Authors:  Jelena Zlatkovic-Lindor; D Kent Arrell; Satsuki Yamada; Timothy J Nelson; Andre Terzic
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

9.  Rbm20-deficient cardiogenesis reveals early disruption of RNA processing and sarcomere remodeling establishing a developmental etiology for dilated cardiomyopathy.

Authors:  Rosanna Beraldi; Xing Li; Almudena Martinez Fernandez; Santiago Reyes; Frank Secreto; Andre Terzic; Timothy M Olson; Timothy J Nelson
Journal:  Hum Mol Genet       Date:  2014-02-28       Impact factor: 6.150

10.  Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?

Authors:  Teresa M Lee; Stephanie M Ware
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.